Howard Hughes Medical Institute’s Dynavax Technologies DVAX Stock Holding History

Howard Hughes Medical Institute’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-21,355	Closed	-$210K	–	24
2021 Q2	$210K	Hold	21,355	–	–	0.07%	23
2021 Q1	$210K	Hold	21,355	–	–	0.07%	23
2020 Q4	$95K	Hold	21,355	–	–	0.02%	22
2020 Q3	$92K	Hold	21,355	–	–	0.03%	21
2020 Q2	$189K	Hold	21,355	–	–	0.08%	22
2020 Q1	$75K	Hold	21,355	–	–	0.02%	22
2019 Q4	$122K	Hold	21,355	–	–	0.04%	25
2019 Q3	$76K	Hold	21,355	–	–	0.02%	25
2019 Q2	$85K	Hold	21,355	–	–	0.04%	25
2019 Q1	$156K	Hold	21,355	–	–	0.04%	27
2018 Q4	$195K	Hold	21,355	–	–	0.06%	29
2018 Q3	$265K	Hold	21,355	–	–	0.08%	27
2018 Q2	$326K	Hold	21,355	–	–	0.08%	27
2018 Q1	$424K	Hold	21,355	–	–	0.11%	27
2017 Q4	$399K	Hold	21,355	–	–	0.1%	28
2017 Q3	$459K	Hold	21,355	–	–	0.11%	31
2017 Q2	$206K	Hold	21,355	–	–	0.04%	124
2017 Q1	$127K	Hold	21,355	–	–	0.02%	131
2016 Q4	$84K	Hold	21,355	–	–	0.02%	134
2016 Q3	$224K	Hold	21,355	–	–	0.06%	120
2016 Q2	$311K	Hold	21,355	–	–	0.1%	106
2016 Q1	$411K	Hold	21,355	–	–	0.09%	88
2015 Q4	$516K	Hold	21,355	–	–	0.08%	93
2015 Q3	$524K	Sell	21,355 -22,000	-51%	-$623K	0.1%	93
2015 Q2	$1.02M	Hold	43,355	–	–	0.22%	74
2015 Q1	$972K	Hold	43,355	–	–	0.13%	68
2014 Q4	$731K	Sell	43,355 -1	-0%	-$15	0.2%	70
2014 Q3	$620K	Hold	43,356	–	–	0.14%	73
2014 Q2	$694K	Hold	43,356	–	–	0.12%	49
2014 Q1	$784K	Hold	43,356	–	–	0.11%	46
2013 Q4	$850K	Hold	43,356	–	–	0.13%	44
2013 Q3	$516K	Hold	43,356	–	–	0.08%	51
2013 Q2	$477K	Buy	+43,356	New	+$913K	0.16%	60

Other funds holding DVAX

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Howard Hughes Medical Institute's DVAX Position: Q3 2021 in Review

Howard Hughes Medical Institute sold out of Dynavax Technologies (DVAX) in Q3 2021, closing a stake of 21,355 shares — an estimated $210K sold.

Howard Hughes Medical Institute first reported a position in DVAX in Q2 2013 and held it in 33 quarters. The position peaked at $1.02M in Q2 2015. 183 funds tracked by Wall St. Rank hold DVAX as of Q3 2021.

Howard Hughes Medical Institute reported no remaining Dynavax Technologies position as of Q3 2021 after selling out during the quarter.
Howard Hughes Medical Institute sold 21,355 Dynavax Technologies shares in Q3 2021, an estimated $210K.
Howard Hughes Medical Institute first reported a position in Dynavax Technologies in Q2 2013 and held it in 33 quarters.
Howard Hughes Medical Institute's Dynavax Technologies position peaked at $1.02M in Q2 2015.
183 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2021.

Based on Howard Hughes Medical Institute's 13F filing for Q3 2021, filed 10 Nov 2021.